Under normal growth conditions, binding of the cyclin B1 to CDK1 is necessary for CDK1 activation and initiation of its phosphorylation at threonine residue 161 (Thr 161), thereby commit the mitochondrial metabolism for adaptive cell cycle progression and resistance of cancer cells [19,20]. This evidence concerns the gene CDK1 and cancer.